Johnson & Johnson EV/Sales
What is the EV/Sales of Johnson & Johnson?
The EV/Sales of Johnson & Johnson is 5.93
What is the definition of EV/Sales?
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
EV/Sales of companies in the Health Care sector on NYSE compared to Johnson & Johnson
What does Johnson & Johnson do?
Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods.
Companies with ev/sales similar to Johnson & Johnson
- Paramount Inc has EV/Sales of 5.92
- Mcphy S.A. Eo 0,12 has EV/Sales of 5.92
- Crossword Cybersecurity Plc has EV/Sales of 5.92
- iShares € Corp Bond 0-3yr ESG UCITS ETF EUR (Dist) has EV/Sales of 5.93
- Budweiser Brewing APAC has EV/Sales of 5.93
- Vixtel Technologies has EV/Sales of 5.93
- Johnson & Johnson has EV/Sales of 5.93
- ASM International NV has EV/Sales of 5.94
- SiteMinder has EV/Sales of 5.94
- Aon plc has EV/Sales of 5.94
- Atlas has EV/Sales of 5.94
- Housing Development Finance has EV/Sales of 5.94
- Avid Bioservices Inc has EV/Sales of 5.94